A 50-year-old woman suffered severe jaundice following a second anaesthetic, two weeks after an anaesthetic which had been followed by fever and malaise. An initial diagnosis of "probable halothane hepatitis" was made. This diagnosis is discussed, together with some implications.
CASE REPORT An apparently healthy Italian woman of 50 years, weighing 78 kg, was admitted for examination under anaesthesia and biopsy of a large uterine polyp, following intermenstrual bleeding of 8 months duration. She had had two normal pregnancies and deliveries. Previous surgery included two operations for varicose veins (5 and 12 years ago) but no details of the anaesthetic agents used were available. Mature age onset diabetes had been diagnosed two years before and was well controlled on glibenclamide. She was on no other drug therapy but an unspecified antibiotic had been given for an upper respiratory tract infection recently. She was a non-smoker and non-drinker with no history of drug abuse, claimed allergy only to penicillin and had never been jaundiced or had contact with a known source of hepatitis.
Physical examination was normal, blood pressure 150/90 mmHg, chest x-ray and ECG normal. Biochemistry results were also normal, and included the following values: bilirubin 6 mmolll, alkaline phosphatase (SAP) 57 u/l, lactic dehydrogenase (LDH) 183 u/l, and glutamate-oxaloacetate transaminase (SGOT) 20 u/l.
The following day an uneventful anaesthetic was given, using thiopentone, nitrous oxide and halothane, lasting half an hour. On the next day, fever of 39°C and mild malaise were noted. Physical examination was normal, micro urine and blood cultures were negative and vaginal swab grew commensals only. The fever lasted 24 hours and there was no jaundice. She was given co-trimoxazole (Bactrim) and discharged on the 4th post operative day, afebrile and well.
As the histological diagnosis was adenoma, she was re-admitted ten days later for hysterectomy. She was now well and physical examination was again normal. Preoperatively, further biochemistry was carried out, but the result (Table 1) was not available to the anaesthetist at the time of going to the theatre. Anaesthesia on the next day consisted of thiopentone, alcuronium, nitrous oxide, oxygen and halothane with controlled normocarbic respiration, and reversal with atropine and neostigmine. Surgery lasted 2Yz hours, during which one unit of compatible whole blood and 1200 ml of Hartmann's solution were infused. Her condition during and after surgery was satisfactory.
On the following morning, she was febrile (39.5 QC) and jaundiced. The fever was intermittent for four days but she was severely ill and jaundiced for three weeks, during which time treatment was conservative and symptomatic, including bed rest, low protein and high carbohydrate diet, albumin, fresh frozen plasma, vitamin K and lactulose. At the end of three weeks, she began to improve rapidly, and was discharged well after six weeks. Some relevant investigations carried out during this time are included in Table 1 . The patient has made a full recovery, but now has an incisional hernia, presumably related to haemorrhage into the wound when clotting ability was reduced.
DISCUSSION
This case history poses some interesting questions, very few of which can be answered with certainty but most of them have important implications for anaesthetic practice. Because the first operation was only for uterine curettage and because of the subsequent course of the illness, it can be reasonably taken that the first elevation of SAP and SGOT represented evidence of hepatic dysfunction. 1. Why did significant but clinically nonapparent hepatitis follow a single short anaesthetic in a patient who was known not to have existing hepatitis?
The diagnostic possibilities lie between intercurrent disease or a drug reaction, and of the latter, a drug given either before or during the anaesthetic. There could be only unsupported speculation in favour of any intercurrent illness. Two drugs had been used preoperatively, glibenclamide and an unspecified antibiotic which had been given for a few days and discontinued about ten days prior to the anaesthetic. Glibenclamide had been in use for two years and is still being used. In respect of the antibiotic, it is highly unlikely as a cause in view of the usual presentations of such reactions, and there is no evidence for it.
Drugs given in association with the anaesthetic include the premedicants pethidine and atropine, and thiopentone, nitrous oxide and halothane. None of these, with the exception of halothane, has been implicated in the production of hepatitis in a well patient.
How often might this occur?
There is no way of knowing how often this sequence of hepatic dysfunction following a single anaesthetic may occur, and it was not suspected at the time in this patient. In a number of reports t ,2,3 there have been similar patients with hepatitis which was discovered by enzyme studies and in some cases confirmed by liver biopsy, but who had minimal or absent clinical signs of that disease.
Since this patient had had previous anaesthesia without problems, she is not one of those rare people who respond to all anaesthesia, whether including halothane or not, with hepatic dysfunction. 4 3. Why did severe, life threatening hepatitis follow a second anaesthetic, ten days after the first?
Although the anaesthetist did not know it at the time, sub-clinical hepatitis was now present and as Strunin 5 points out, "if there is evidence that acute hepatitis is still present, anaesthesia and surgery should be delayed until the hepatitis has resolved ... giving any anaesthetic to a patient with acute hepatitis will almost Anaesthesia and Inlensive Care, Vol. VIII, No. 2, May, 1980 certainly be followed by further deterioration in liver function".
Additional drugs used had now included Bactrim, alcuronium and neostigmine and the same remarks as above can be applied to them. Although one unit of whole blood had been infused, the subsequent clinical course rules out an incompatible transfusion or pigment overload. 4. Is there any evidence to implicate halothane in the described events?
The short answer is that there can be no direct evidence, as there are no specific diagnostic features of hepatitis which may be attributed to halothane to distinguish it from that due to other causes of acute hepatitis or other drugs. Certainly, this patient was too ill to attempt histopathological diagnosis. By inference, however, she was thought from the outset to be possibly suffering from halothane hepatitis and time has not provided a more likely alternative. Strunin 5 refers to this possibility in these terms: "it now seems clear that, in rare circumstances, liver damage is associated with halothane anaesthesia, often following repeated administration: however, the mechanism is by no means clear". There is still great difference of opinion regarding the incidence of this association, and also regarding the frequency with which it may cause death.
More positive evidence, though still short of certainty, arises from the fact that this patient was an obese female aged 50 who had had two surgical procedures within two weeks and was shown to have organ-specific autoimmunity. Strunin 5 says, "it seems that certain groups of patients are particularly likely to develop halothane hepatitis. These include patients subjected to repeated surgical procedures at short intervals of time, and obese middle-aged female patients with evidence of organ-specific autoimmunity" .
If this patient's hepatic dysfunction was caused by or exacerbated by halothane, the mechanism is at present not known. There would be some support for a hypersensitivity or an immune response. The pathways which are currently thought to be possible were recently referred to by Cousins 6 and discussed in detail by Cohen. 7 5. Would a similar outcome have followed the second anaesthetic if another agent had been Anaesthesia and InTensive Care, Vol. VIII, No. 2. May, 1980 used, now given the existing hepatitis?
Since any general anaesthetic is contraindicated in those with acute hepatitis, except for emergencies, this patient should have had her hysterectomy deferred, at least until her SOOT was normal. But occasionally an anaesthetic will be necessary, and the anaesthetist can only be guided by conventional wisdom.
It is not known whether an obese patient is more at risk than one who is not obese. There is some tentative evidence that this might be so based on human and animal observations. 8 ,9 It has been suggested that a fatty liver may take up and metabolise greater fractions of halothane. Halothane is metabolised in man to about 12070 in the first six hours following administration, which is a higher rate than occurs in any other species. 7 If a second anaesthetic must be given within a short interval, it would be logical to use agents which are metabolised to a lesser extent in the liver. Currently, enflurane is often chosen for this reason. No such entity as enflurane hepatitis has been described, although some cases have been reported which raise some doubts about possible hepatic effects.IO,11 When it is used in this way, it is generally assumed that hepatitis is not present, in the absence of relevant clinical signs. This case history would not support such an assumption. It would appear to be more prudent still not to substitute one fluorinated hydrocarbon for another, but to use regional anaesthesia if possible, and if not, some other combination of agents. 6. Are there any lessons for future patient management?
The value of aminotransferase (SOOT and SOPT) levels as predictors of possible trouble has been prospectively studied. SOOT is present in large quantity in heart, liver, skeletal muscle and kidney. Its level rises when there is damage to any of these tissues, so elevations are common following major surgery, increasing liver damage and myocardial infarction. SOPT (glutamate-pyrurate transaminase) is similarly distributed but in lower concentrations and is less commonly used.
SchemeF used SOOT SO PT and LDH to screen every patient due to have anaesthesia in one hospital in one year. Of 7,620 patients, unexpected enzyme elevations were found in 11 and these were all ASA grade I and apparently fit. Their surgery was deferred and they were further investigated. Three of them went on to become jaundiced, and the eventual diagnoses in the group were infectious mononucleosis 2, viral hepatitis 3, cirrhosis 2, alcoholic hepatitis 1, chronic hepatitis 1 and? industrial toxin 1. It may be speculated what would have happened if these patients had been given halothane anaesthesia, and if they had developed further hepatic damage, what diagnosis would then have been made?
It is considered to be unwarranted and impractical to have such tests done routinely as a pre-operative screen, but a case could be made for this to be done in some institutions as an index to overall community patterns. At the present time, the objective of cost containment would probably rule out their general use. Nevertheless, the prospective studies of TrowelJl and Wright l2 indicate that the use of enzyme assays are sufficiently good predictors of hepatic damage, taken in conjunction with other information, even when there are no clinical signs. On the basis of the sequence of events reported in this case history, it would seem advisable to carry out such tests on all patients who are due to have repeat anaesthesia within three weeks of a previous anaesthetic, and especially if the first anaesthetic has included halothane. This is an area of concern for anaesthetists on account of the lack of definition of risk. Inman and Mushin 13 estimated that about 7f1!o of patients having anaesthesia in the U.K. have a repeat within a month. Adoption of the above suggestion would not greatly expand costs and could serve as a predictor of increased risk even in the absence of a pre-operative figure for comparison. A further advantage, when nonhalothane anaesthesia was used on the subsequent occasion or occasions, would be the gathering of information on the comparable effects of such agents in these circumstances. This is generally admitted to be one of the essential areas of information which is lacking in the continuing discussion of hepatitis following repeated anaesthesia. Some studies already done have yielded information which unfortunately is difficult to evaluate. 14 • 3 Strunin IS offered as an opinion that "assessing postoperative liver function by changes in transaminases alone is unrewarding". What is unrewarding may be either uneconomical, statistically insignificant, dangerous or frankly useless, and may therefore need to be judged by differing standards. It would be rewarding, even though it may be uncommon, to be able to avoid anaesthesia in the presence of otherwise unsuspected acute hepatic dysfunction.
